Shanmugam Muthusamy 的 Form 4/A 修正申報
修正Ani Pharmaceuticals Inc（ANIP），2023/11/20 申報
- 申報編號
- 0001870913-23-000016
- 申報時間
- 2023/11/20
- 交易日
- 2023/11/14-11/16
- 申報延遲
- 6 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2023/11/16
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $196.1 萬。交易後 6 天申報。
這份修正申報取代了 0001870913-23-000013（2023/11/16 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Shanmugam MuthusamyCIK 0001870913 | 董事、高階主管（HEAD OF R&D, COO-NOVITIUM OPS） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive
表 I 有 1 筆交易的價格引用這則附註。
備註
This amendment is being filed to address an administrative error in reporting the number of shares sold in a transaction on November 14, 2023.